
Ascendis Pharma A/S ASND
$ 212.81
1.71%
Annual report 2024
added 12-06-2025
Ascendis Pharma A/S DSO Ratio 2011-2025 | ASND
Annual DSO Ratio Ascendis Pharma A/S
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 132 | 98.3 | 62 | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 132 | 62 | 97.5 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.79 | 2.35 % | $ 795 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.04 | 4.83 % | $ 235 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 1.17 | 4.46 % | $ 6.38 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Aptevo Therapeutics
APVO
|
79 | $ 0.93 | -8.81 % | $ 257 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.18 | -25.03 % | $ 392 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.1 | 0.16 % | $ 7.46 B | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.81 | 1.36 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 9.48 | 0.96 % | $ 139 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
2.47 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
134 | $ 591.15 | 0.02 % | $ 44.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.53 | -0.39 % | $ 15.9 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 12.37 | 2.06 % | $ 814 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 10.81 | 2.95 % | $ 699 M | ||
|
Biogen
BIIB
|
57.9 | $ 176.33 | 0.86 % | $ 25.7 B | ||
|
Abeona Therapeutics
ABEO
|
387 | $ 5.41 | 2.08 % | $ 116 M | ||
|
ADiTx Therapeutics
ADTX
|
621 | $ 1.14 | -9.52 % | $ 15 K |